hematologyandoncology.net hematologyandoncology.net

HEMATOLOGYANDONCOLOGY.NET

Hematology & Oncology – Hematology & Oncology

Are Direct Acting Oral Anticoagulants Ready for Prime-Time Use in Cancer-Related Thrombosis? Michael Blake Streiff, MD. H&O How common is thrombosis in patients being treated for cancer? MS Approximately 20% to 25% of patients with venous thromboembolism (VTE) at a typical […]. Emerging Options for Combination Therapy in Multiple Myeloma. Adriana C. Rossi, MD. Update on Hairy Cell Leukemia. Robert J. Kreitman, MD, and Evgeny Arons, PhD. The Timing of Molecular Imaging in Prostate Cancer. Abstract: It has...

http://www.hematologyandoncology.net/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR HEMATOLOGYANDONCOLOGY.NET

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 14 reviews
5 star
3
4 star
6
3 star
3
2 star
0
1 star
2

Hey there! Start your review of hematologyandoncology.net

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.5 seconds

FAVICON PREVIEW

  • hematologyandoncology.net

    16x16

  • hematologyandoncology.net

    32x32

CONTACTS AT HEMATOLOGYANDONCOLOGY.NET

Millennium Medical Publishing

Steven Kurlander

611 ●●●●dway

Sui●●●310

New●●●ork , New York, 10012

United States

212-●●●●2211
do@clinicaladvances.com

View this contact

Millennium Medical Publishing

Steven Kurlander

611 ●●●●dway

Sui●●●310

New●●●ork , New York, 10012

United States

212-●●●●2211
do@clinicaladvances.com

View this contact

Millennium Medical Publishing

Steven Kurlander

611 ●●●●dway

Sui●●●310

New●●●ork , New York, 10012

United States

212-●●●●2211
do@clinicaladvances.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2013 January 16
UPDATED
2014 January 02
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 12

    YEARS

  • 9

    MONTHS

  • 9

    DAYS

NAME SERVERS

1
ns03.domaincontrol.com
2
ns04.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
Hematology & Oncology – Hematology & Oncology | hematologyandoncology.net Reviews
<META>
DESCRIPTION
Are Direct Acting Oral Anticoagulants Ready for Prime-Time Use in Cancer-Related Thrombosis? Michael Blake Streiff, MD. H&O How common is thrombosis in patients being treated for cancer? MS Approximately 20% to 25% of patients with venous thromboembolism (VTE) at a typical […]. Emerging Options for Combination Therapy in Multiple Myeloma. Adriana C. Rossi, MD. Update on Hairy Cell Leukemia. Robert J. Kreitman, MD, and Evgeny Arons, PhD. The Timing of Molecular Imaging in Prostate Cancer. Abstract: It has...
<META>
KEYWORDS
1 current issue
2 supplements
3 archives
4 mmp home
5 menu
6 hematology
7 in this issue
8 myeloma
9 leukemia
10 prostate cancer
CONTENT
Page content here
KEYWORDS ON
PAGE
current issue,supplements,archives,mmp home,menu,hematology,in this issue,myeloma,leukemia,prostate cancer,kidney cancer,from recent issues,breast cancer,myelodysplastic syndromes,pancreatic cancer,colorectal cancer,lymphoma,latest news,tweets,hemonc
SERVER
nginx/1.12.2
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Hematology & Oncology – Hematology & Oncology | hematologyandoncology.net Reviews

https://hematologyandoncology.net

Are Direct Acting Oral Anticoagulants Ready for Prime-Time Use in Cancer-Related Thrombosis? Michael Blake Streiff, MD. H&O How common is thrombosis in patients being treated for cancer? MS Approximately 20% to 25% of patients with venous thromboembolism (VTE) at a typical […]. Emerging Options for Combination Therapy in Multiple Myeloma. Adriana C. Rossi, MD. Update on Hairy Cell Leukemia. Robert J. Kreitman, MD, and Evgeny Arons, PhD. The Timing of Molecular Imaging in Prostate Cancer. Abstract: It has...

INTERNAL PAGES

hematologyandoncology.net hematologyandoncology.net
1

Current and Novel Treatment Options for Peripheral T-Cell Lymphoma

http://www.hematologyandoncology.net/index.php/archives/july-2015/current-and-novel-treatment-options-for-peripheral-t-cell-lymphoma

Sign Up for Email Updates. For Email Newsletters you can trust. July 2, 2015. Current and Novel Treatment Options for Peripheral T-Cell Lymphoma. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. Steven M. Horwitz, MD. Memorial Sloan Kettering Cancer Center. New York, New York. What is peripheral T-cell lymphoma (PTCL)? The second most common subtype is angioimmunoblastic T-cell lymphoma. These diseases are usually nodal-based. T-cell lymphomas have a higher frequency o...What ...

2

Stool DNA Testing: A New, Noninvasive Option for Colorectal Cancer Screening

http://www.hematologyandoncology.net/index.php/archives/july-2015/stool-dna-testing-a-new-noninvasive-option-for-colorectal-cancer-screening

Sign Up for Email Updates. For Email Newsletters you can trust. July 4, 2015. Stool DNA Testing: A New, Noninvasive Option for Colorectal Cancer Screening. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. David A. Ahlquist, MD. What are the limitations of the existing methods of colorectal cancer (CRC)screening? How can the noninvasive multitarget stool DNA test you helped develop make a difference? How does the stool DNA test work? Testing is performed on samples sent to a ce...

3

Second-Generation ALK Inhibitors

http://www.hematologyandoncology.net/index.php/archives/july-2015/second-generation-alk-inhibitors

Sign Up for Email Updates. For Email Newsletters you can trust. July 3, 2015. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. Hiroyuki Mano, MD, PhD. Department of Cellular Signaling. Graduate School of Medicine. Bunkyo, Tokyo, Japan. What is the mechanism of action for second-generation anaplastic lymphoma kinase (ALK) inhibitors? In 2010, we published a study in the New England Journal of Medicine. That describes the mechanism by which EML4-ALK. Positive chronic myeloid leu...

4

About

http://www.hematologyandoncology.net/index.php/about

Sign Up for Email Updates. For Email Newsletters you can trust. Clinical Advances in Hematology & Oncology (CAH&O). Is a monthly peer-reviewed journal reaching nearly 26,000 hematology and oncology clinicians. More Chemo Drugs Don't Improve Treatment of Rare Bone Cancer. Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency. Lung Cancer Doctors Eye Merck's Keytruda Over Bristol's Opdivo.

5

The Effect of Cancer Treatment on Cognitive Function

http://www.hematologyandoncology.net/index.php/archives/july-2015/the-effect-of-cancer-treatment-on-cognitive-function

Sign Up for Email Updates. For Email Newsletters you can trust. July 9, 2015. The Effect of Cancer Treatment on Cognitive Function. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. Arash Asher, MD, and Jamie S. Myers, PhD, RN, AOCNS. Arash Asher, MD. Samuel Oschin Comprehensive Cancer. University of California, Los Angeles. 8700 Beverly Boulevard, AC 1109. Los Angeles, California 90048. E-mail: Arash.Asher@cshs.org. To receiving any treatment. For example, several studies ...

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

hemonc.tv hemonc.tv

Evolving Treatments in Acute Myeloid Leukemia

http://www.hemonc.tv/Home/Leukemia/AllLeukemiaArticles/EvolvingTreatmentsinAcuteMyeloidLeukemia.aspx

You are here :. Evolving Treatments in Acute Myeloid Leukemia. Renal Cell Carcinoma (Kidney). Evolving Treatments in Acute Myeloid Leukemia. Gail J. Roboz, MD, Associate Professor of Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York. Could you give some background on acute myeloid leukemia (AML)? How does AML prognosis compare with other hematologic malignancies? A recent survey by Sant and colleagues was published in the. Describing hematologic mal...

hemonc.tv hemonc.tv

Should Lung Cancer Screening With Low-Dose Computed Tomography Be Routine for Smokers and Former Smokers?

http://www.hemonc.tv/Home/LungCancer/AllLungCancerArticles/ShouldLungCancerScreeningWithLow-DoseComputedTomographyBeRoutineforSmokersandFormerSmokers.aspx

You are here :. All Lung Cancer Articles. Should Lung Cancer Screening With Low-Dose Computed Tomography Be Routine for Smokers and Former Smokers? Renal Cell Carcinoma (Kidney). Should Lung Cancer Screening With Low-Dose Computed Tomography Be Routine for Smokers and Former Smokers? Clinical Advances in Hematology and Oncology. October 2014, Volume 12, Issue 10. Should Low-Dose CT Be Routine in These Patients? James R. Jett, MD, is a professor of medicine at National Jewish Health in Denver, Colorado.

hemonc.tv hemonc.tv

Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer

http://www.hemonc.tv/Home/ColorectalCancer/AllColorectal(GI)Articles/BevacizumabvsEGFRAntibodiesinMetastaticColorectalCancer.aspx

You are here :. Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer. Renal Cell Carcinoma (Kidney). Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer. Alan P. Venook, MD, Professor, Department of Medicine, Hematology/Oncology, University of California, San Francisco. What are the benefits and limitations of bevacizumab in metastatic colorectal cancer? What are the benefits and limitations of epidermal growth factor receptor (EGFR) antibodies for metastatic colorectal cancer? Wild-...

hemonc.tv hemonc.tv

Education

http://www.hemonc.tv/Education.aspx

You are here :. Renal Cell Carcinoma (Kidney). The CME/CE courses at HemOnc.tv cover a wide range of topics important to the practicing health care provider. We invite you to browse through the menu below where you'll find programs on a wide range of disease states and related issues. Neuroendocrine Tumors - NETs. Renal Cell Carcinoma (Kidney). Currently viewing : Lecture Series. 2014 Society of Hematologic Oncology Annual Meeting - Session X - Conference Highlights. And MD Anderson Cancer Center. Treatm...

hemonc.tv hemonc.tv

Ibrutinib combined with bendamustine and rituximab in previously treated CLL/SLL: First results phase III study - Leukemia - Videos :: HemOnc

http://www.hemonc.tv/Videos/TabId/1811/VideoId/1397/Ibrutinib-Combined-With-Bendamustine-And-Rituximab-In-Previously-Treated-CLLSLL-First-Results-Phase-III-Study.aspx

You are here :. Renal Cell Carcinoma (Kidney). The HemOncTV Network is a way to learn and interact with your peers. If you’d like to find out more about this topic you may submit a question regarding the current video playing in "Ask the Experts". Please select a video from the list below. Ibrutinib combined with bendamustine and rituximab in previously treated CLL/SLL: First results phase III study. ASCO 2015 - Abstract LBA7005 Link to website. Please enter the Question! Please enter your Email Address!

hemonc.tv hemonc.tv

ASPECCT phase 3 study of pmab vs cmab in chemorefractory wild-type KRAS exon 2 mCRC - GI/Colorectal Cancer - Videos :: HemOnc

http://www.hemonc.tv/Videos/TabId/1811/VideoId/1398/ASPECCT-Phase-3-Study-Of-Pmab-Vs-Cmab-In-Chemorefractory-Wildtype-KRAS-Exon-2-MCRC.aspx

You are here :. Renal Cell Carcinoma (Kidney). The HemOncTV Network is a way to learn and interact with your peers. If you’d like to find out more about this topic you may submit a question regarding the current video playing in "Ask the Experts". Please select a video from the list below. ASPECCT phase 3 study of pmab vs cmab in chemorefractory wild-type KRAS exon 2 mCRC. ASCO 2015 - Abstract 3586 (jpg). Use the space below to submit your questions to the HemOnc.TV Experts. (Login required.). Review of ...

hemonc.tv hemonc.tv

Targeted Therapy vs Chemotherapy: Which Has Had More Impact on Survival in Lung Cancer?

http://www.hemonc.tv/Home/LungCancer/AllLungCancerArticles/TargetedTherapyvsChemotherapyWhichHasHadMoreImpactonSurvivalinLungCancer.aspx

You are here :. All Lung Cancer Articles. Targeted Therapy vs Chemotherapy: Which Has Had More Impact on Survival in Lung Cancer? Renal Cell Carcinoma (Kidney). Targeted Therapy vs Chemotherapy: Which Has Had More Impact on Survival in Lung Cancer? Clinical Advances in Hematology and Oncology. November 2014, Volume 12, Issue 11. Chemotherapy and targeted therapy both have earned their place in the treatment of lung cancer, but which has made the larger contribution? HARD TO PROVE, BUT IMPOSSIBLE TO IGNORE.

hemonc.tv hemonc.tv

Videos

http://hemonc.tv/Videos.aspx

You are here :. Renal Cell Carcinoma (Kidney). The HemOncTV Network is a way to learn and interact with your peers. If you’d like to find out more about this topic you may submit a question regarding the current video playing in "Ask the Experts". Please select a video from the list below. Review of Abstract #401: Clinical and Prognostic Significance of 3q26 Rearrangements and Other Chromosome 3 Abnormalities in CML in Era of TKI’s. Please enter the Question! Please enter your Email Address! Review of Ab...

UPGRADE TO PREMIUM TO VIEW 28 MORE

TOTAL LINKS TO THIS WEBSITE

36

SOCIAL ENGAGEMENT



OTHER SITES

hematology2016.ru hematology2016.ru

Главная

14-16 апреля 2016 года в Москве проведен III Конгресс Гематологов России! На заседаниях Конгресса были затронуты вопросы разработки и внедрения новых методов диагностики и лечения заболеваний системы крови у взрослых и детей с доказательной объективной оценкой долгосрочных результатов эффективности терапии, базирующихся на данных российских и международных клинических исследований, фундаментальных и поисковых научно-исследовательских и прикладных работ. В ходе организации события компании. Мы искренне на...

hematology88.blogfa.com hematology88.blogfa.com

هماتولوژی (شگفتی های خون)

هماتولوژی (شگفتی های خون). هفته سوم تیر 1392. هفته دوم تیر 1392. هفته او ل تیر 1392. هفته سوم خرداد 1392. سایت جامع علوم آزمایشگاهی و پزشکی(فاسکو). انجمن علمی انتقال خون ایران. شبکه انکولوژی جهانی(مرکز هماتولوژی). انجمن مدیکال آنکولوژی و هماتولوژی ایران. دانلود کتاب های هماتولوژی. جامعه مجازی آزمایشگاهیان کشور. انجمن دکترای علوم آزمایشگاهی تشخیص طبی ایران. مرکز تحقیقات هماتولوژی, انکولوژی و پیوند سلولهای بنیادی. پورتال سازمان انتقال خون ايران. بانک اطلاعاتی اهدا كنندگان سلولهای بنیادی ایران. برای دیدن تص...

hematology91ahvaz.blogsky.com hematology91ahvaz.blogsky.com

خون شناسی وبانک خون آزمایشگاهی

خون شناسی وبانک خون آزمایشگاهی. پنجشنبه 24 اردیبهشتماه سال 1394. چک لیست اعتبار بخشی آزمایشگاه بیمارستان. یکشنبه 7 مهرماه سال 1392. آری از پشت کوه آمده ام ،. چه میدانستم: اینور کور باید،. برای ثروت حرام خورد،. برای عشق خیانت کرد ،. برای خوب دیده شدن باید دیگری را بد نشان داد ،. برای به عرش رسیدن باید دیگری را به فرش کشاند ،. وقتی هم با تمام سادگی دلیلش را میپرسم،. می گویند : از پشت کوه آمده،. ترجیح می دهم به پشت کوه برگردم و تنها دغدغه ام سالم برگرداندن گوسفندان از دست گرگ ها باشد،. نباید همولیز ایجاد کند.

hematologyadvance.net hematologyadvance.net

Domain Registered at Safenames

Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.

hematologyadvance.org hematologyadvance.org

Domain Registered at Safenames

Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.

hematologyandoncology.net hematologyandoncology.net

Hematology & Oncology – Hematology & Oncology

Are Direct Acting Oral Anticoagulants Ready for Prime-Time Use in Cancer-Related Thrombosis? Michael Blake Streiff, MD. H&O How common is thrombosis in patients being treated for cancer? MS Approximately 20% to 25% of patients with venous thromboembolism (VTE) at a typical […]. Emerging Options for Combination Therapy in Multiple Myeloma. Adriana C. Rossi, MD. Update on Hairy Cell Leukemia. Robert J. Kreitman, MD, and Evgeny Arons, PhD. The Timing of Molecular Imaging in Prostate Cancer. Abstract: It has...

hematologyatlas.com hematologyatlas.com

ATLAS OF HEMATOLOGY

hematologyawards.com hematologyawards.com

Open Docs Login

hematologybillers.com hematologybillers.com

P1 Billing LLC

P1 Billing has provided world class billing services to Hematology practices such as yours, throughout the U.S. Our seasoned staff of expert billing professionals is able to assist your practice in all aspects of the business of Hematology, in all sub-specialties. We are committed to competent, compliant processes that maximize our clients’ cash flow. GETTING APPROPRIATE REIMBURSEMENT FOR YOUR HARD WORK GROWS MORE COMPLICATED EACH DAY. Unique Hematology Billing Capabilities. Coding of E&M services. Provi...

hematologybilling.com hematologybilling.com

Acsel Medical Solutions

Since 1977, Acsel Medical Solutions has provided world class billing services to Hematology practices such as yours, throughout the U.S. Our seasoned staff of expert billing professionals is able to assist your practice in all aspects of the business of Hematology, in all sub-specialties. We are committed to competent, compliant processes that maximize our clients’ cash flow. GETTING APPROPRIATE REIMBURSEMENT FOR YOUR HARD WORK GROWS MORE COMPLICATED EACH DAY. Unique Hematology Billing Capabilities.

hematologycenter.com hematologycenter.com

HematologyCenter.com is for Sale! @ DomainMarket.com, Maximize Your Brand Recognition with a Premium Domain

Ask About Special March Deals! What Are the Advantages of a Super Premium .Com Domain? 1 in Premium Domains. 300,000 of the World's Best .Com Domains. Available For Immediate Purchase. Safe and Secure Transactions. 24/7 Customer Support: 888-694-6735. Search For a Premium Domain. Or Click Here To Get Your Own Domains Appraised. Find more domains similar to HematologyCenter.com. We are constantly expanding our inventory to give you the best domains available for purchase! Domains Added in the Past Month.